Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Research
Sarcomatrix to Present its Latest Advancements in the Development of its Lead Drug Candidate, S-969
Research
A Novel “Mini-CRISPR” Could Be More Successful at Editing the Dystrophin Gene
Research
Everything You Should Know About Genethon’s Gene Therapy GNT0004 for Duchenne Muscular Dystrophy
Press Releases
Sidra Medicine Establishes Gene Therapy Center for Rare Genetic Diseases in Qatar
Research
5 DMD Researches You Should Follow up in 2025
Research
Roche Announces New Results from the EMBARK Study of Elevidys in Outpatients with Duchenne Muscular Dystrophy (DMD)
Approved Treatments
FDA-Approved Treatments for DMD (Duchenne Muscular Dystrophy)
Press Releases
Will Genethon and Eukarÿs Partnership Reduce the Cost of Gene Therapies?
Press Releases
Belief BioMed Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate BBM-D101
1
2
3
...
5
Page 2 of 5
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
DMD
Micro Dystrophin: 5 Critical Questions Everyone Is Thinking About
Press Releases
SonoThera Ultrasound-Mediated Delivery Method Can Deliver Full-Length Dystrophin to Cells
Press Releases
Scribe Therapeutics and Prevail Therapeutics to Share In Vivo CRISPR-based Genome Editing Data at ASGCT 2025